Eric Lefkofsky: Enhancing Cancer Care Through Data Approach
Since 2015, Eric Lefkofsky has been battling on the most effective approach on Cancer treatment. The CEO and co-founder of Tempus Labs leads the health tech company staff to tackle the complex disease using data approach. Cancer is a complex disease because it camouflages and poses as part of the body components thus protecting its cells from the body’s defense mechanism. Ordinarily, foreign elements in the body are detected and expelled by the defense system. However, the cancerous processes camouflage to be part of the normal body functions that gradually destroy the body cells.
The principal objective behind establishment of Tempus Labs is to improve care of cancer patients and loved ones. The diagnosis approach involves gathering, cleaning, and organizing data of different cancer patients for the purpose of optimizing care. Tempus Labs obtains information from top academic institutions as well as specific cancer treatment centers. Optimizing cancer therapy and treatment is the primary goal of Tempus Labs led by its CEO, Lefkofsky.
One of the challenges in cancer treatment is access to patient data by the physicians. For a long time, there has been a rift between storage and access of patient data. Access to such data is critical to therapy development because physicians can establish patterns and similar behavior of the cancerous processes thus prescribe suitable treatment. This is one of Tempus Labs’ fundamentals. The tech company strives to collect and centralize data through a machine learning platform. The platform integrates molecular data and clinical records. This enhances the cancer treatment approach considering therapy is more personalized.
According to Lefkofsky, molecular data is the primary basis of all manner of treatment in the field of medicine. Although it is as an integral approach in therapy, Eric Lefkofsky registers his dissatisfaction on the one-sided approach. Molecular data entails a patient’s RNA and DNA. Tempus uses analysis and sequencing method to obtain data from genes. Additionally, the molecular data is matched with clinical data to determine the best mode of therapy for a specific patient. The primary goal of Lefkofsky at Tempus is to initiate personalized medicine that has been an area of medical research for more than a decade. Gene sequencing and data analysis helps the Tempus staff to be precise in developing and prescribing medicine for cancer patients. According to Lefkofsky, the platform is not only for Tempus Labs but also available to neurologists and Oncologists.
Apart from Tempus, Eric Lefkofsky is also the co-founder of Echo Global Logistics, Light bank, InnerWorkings, and Uptake Technologies. Evidently, Lefkofsky has not only ventured in the health tech industry but also in transportation and logistics. Currently, he is a professor at the University of Chicago’s Booth School of Business. He also served as a tutor at Northwestern University as well as at DePaul University.
Besides his investments and contribution towards Cancer care, Lefkofsky also engages in charitable activities. He is the founder of Lefkofsky Family Foundation, which he runs with his wife. The foundation drives initiatives in improving medicine, education, culture as well as the fundamental human rights. Lefkofsky and his wife are also key contributors and members of The Giving Pledge. In addition to this, Lefkofsky sits on the board of management of the Lurie’s Children’s Hospital of Chicago. He is also part of The Museum of Science and the Art Institute of Chicago trustee boards.
Image Source: Pixabay
Notice: This post may contain affiliate links. If you click a link and make a purchase, we may financially benefit from your transaction, at no additional cost to you. Thank you for your support.
------------------------------------------------------------------------------------------------------
Please be sure to visit David over at Random Thoughts and Observations.
I respond to all comments on this blog, ideally within 24 hours. Please check back here for a response to your comment. Thank you!
Please subscribe to David's YouTube Channel. Thanks!
Very interesting post.
ReplyDeleteThanks, Ellen. I hope that you're having a great day so far. :)
Delete